查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2030106

Western Blotting市場－全球產業規模、佔有率、趨勢、機會、預測：按產品、應用、最終用戶、地區和競爭對手分類，2021-2031年

Western Blotting Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Application, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 182 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球蛋白質印跡市場預計將從 2025 年的 21.8 億美元成長到 2031 年的 31.4 億美元，複合年成長率為 6.27%。

蛋白質印跡法（Western blotting）是分子生物學中的一項核心技術，它利用凝膠電泳和免疫檢測來鑑定和半定量複雜生物混合物中的特定蛋白質。此技術的需求主要受以下因素驅動：全球感染疾病和慢性病發病率的上升，這些疾病需要進行全面的蛋白質分析；以及蛋白質體學研究的日益普及。此外，生命科學領域研發的大量投入，以及個人化醫療領域對生物標記發現的迫切需求，都在加速市場成長。

市場概覽
預測期 2027-2031
市場規模：2025年 21.8億美元
市場規模：2031年 31.4億美元
複合年成長率：2026-2031年 6.27%
成長最快的細分市場 裝置
最大的市場 北美洲

美國國立衛生研究院 (NIH) 的報告顯示，生物醫學領域的巨額投資推動了這一趨勢，預計到 2025 年，研究津貼將為美國帶來 941.5 億美元的新經濟活動。然而，儘管成長環境有利，市場仍面臨許多挑戰。主要因素是蛋白質印跡實驗設備和試劑的高昂成本。此外，實驗操作複雜且耗時，也持續阻礙市場的進一步擴張。

市場促進因素

全球蛋白質印跡市場受到藥物研發和蛋白質體學研究活性化的顯著影響。隨著研究人員對蛋白質修飾、相互作用和功能的深入探索，蛋白質印跡仍然是檢驗科學發現的重要工具。準確識別和定量特定蛋白質的能力對於確定治療標靶和闡明疾病機制至關重要。在藥物研發中，此方法有助於評估新型候選藥物及其對細胞內蛋白質表現的影響。 BioSpace在2026年3月指出，16家大型製藥企業在2025年總合投入1,590億美元用於研發，凸顯了蛋白質分析應用領域的巨額投資。對製藥研發的持續投入確保了對蛋白質印跡等可靠蛋白質分析技術的持續需求。

此外，醫藥和生技產業的強勁成長是推動市場發展的主要動力。這一行業的擴張帶動了對先進設備的需求成長，這些設備用於支援藥物研發、品質保證以及生物相似藥和生物製藥的生產。蛋白質印跡法（Western blotting）廣泛應用於這些領域，用於確認抗體特異性、監測表現量和檢驗蛋白質純度，從而確保新型治療方法的安全性和有效性。為了佐證這一動態趨勢，Xtalks在2025年12月指出，主要製藥公司在2025年10月和11月兩個月內，在生技領域的收購支出超過360億美元。這反映出對蛋白質進行全面表徵的迫切需求。這些大規模的併購凸顯了該產業的持續擴張和重組，直接推動了對蛋白質分析工具的需求。同時，領先的臨床診斷和生命科學產品供應商Bio-Rad Laboratories公佈，其2025年全年淨銷售額為25.832億美元。

市場挑戰

由於關鍵試劑和專用設備成本高昂，全球蛋白質印跡市場面臨許多障礙。這些經濟限制嚴重限制了該技術的廣泛應用，對新興診斷檢查室、小規模研究團隊和預算有限的學術機構造成了不成比例的影響。購置先進設備所需的大量初始投資，加上持續購買高品質檢測試劑、膜和抗體的成本，給這些機構帶來了沉重的經濟負擔。

儘管生物製藥產業投入龐大（生物技術創新組織 (BIO) 的報告顯示，2024 年生物製藥創業投資將達到 260 億美元），但單一蛋白質印跡實驗設備的高昂成本阻礙了市場快速擴張和滲透到各種臨床和研究環境中。持續的成本負擔導致許多潛在用戶在購買新系統或升級現有蛋白質印跡實驗設備時猶豫不決。因此，新技術的普及被延緩，用戶仍然依賴過時且低效的技術。

市場趨勢

全球蛋白質印跡市場正因高通量和自動化系統的日益普及而發生變革，這些系統顯著提高了實驗的可重複性和效率。這些創新技術克服了手動操作的常見弊端，例如耗時過長和實驗結果不穩定，使科學家能夠更可靠地處理更多樣本。向自動化流程的轉變正在加速研發進程，尤其是在生物技術和製藥領域，廣泛的檢驗和篩檢已成為標準流程。為了佐證這一趨勢，《歐洲生物技術雜誌》2026年2月3日的一篇報導詳細介紹了領先的生命科學公司賽多利斯(Sartorius)在2025年投資了4.42億歐元。部分資金用於擴大生物製程生產網路，這清楚地表明了該行業致力於擴大營運規模並實施高效自動化工作流程的決心。

除了自動化之外，小型化、無凝膠電泳平台的興起也加速了市場擴張，因為它們能夠實現更快、更易於使用且通常解析度更高的蛋白質分析。這些系統無需傳統凝膠，即可提供更快的檢測結果，同時減少試劑和樣品用量。這對於診斷和研究環境中的快速決策至關重要。這些先進且節省空間的平台正在加速其在各種實驗室環境中的應用，尤其是在需要分散式檢查或空間有限的環境中。為了反映市場對這些現代化解決方案日益成長的需求，Bio-Techne 公司於 2025 年 8 月 6 日發布的 2025 年第四季度財報顯示，其以 Simple Western 平台為核心的蛋白質科學部門當季淨銷售額達 2.265 億美元，同比成長 6%。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球蛋白質印跡市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依產品分類（設備、耗材）
    • 按應用領域分類（生物醫學和生物化學研究、疾病診斷、農業、食品和飲料及其他應用）
    • 依最終用戶（診斷檢查室機構、製藥和生技公司）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美蛋白質印跡市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲蛋白質印跡市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區蛋白質印跡市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲蛋白質印跡市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲蛋白質印跡市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球蛋白質印跡市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche Ltd.
  • Danaher Corporation
  • EMD Millipore Corporation.
  • Bio-Rad Laboratories, Inc.
  • PerkinElmer Inc.
  • LI-COR, Inc.
  • Bio-Techne Corporation
  • QIAGEN NV
  • Advansta Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 15175

The Global Western Blotting Market is anticipated to expand from USD 2.18 billion in 2025 to USD 3.14 billion by 2031, reflecting a compound annual growth rate (CAGR) of 6.27%. As a core molecular biology method, Western blotting utilizes gel electrophoresis and immunodetection to identify and semi-quantify specific proteins in complex biological mixtures. The demand for this technique is largely fueled by the growing worldwide incidence of infectious and chronic illnesses that necessitate comprehensive protein analysis, as well as an increasing emphasis on proteomics research. Additionally, market growth is accelerated by substantial investments in life sciences research and development, along with a surging need for biomarker discovery within the field of personalized medicine.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 2.18 Billion
Market Size 2031USD 3.14 Billion
CAGR 2026-20316.27%
Fastest Growing SegmentInstruments
Largest MarketNorth America

Highlighting the massive scale of biomedical investments, the National Institutes of Health reported that research grants spurred $94.15 billion in new economic activity throughout the United States in 2025. However, even with this favorable growth environment, the market faces notable obstacles, primarily the steep expenses tied to Western blotting equipment and reagents. Furthermore, the intricate and time-consuming nature of the procedures continues to hinder broader market expansion.

Market Driver

The Global Western Blotting Market is heavily influenced by the rise in drug discovery efforts and proteomics research. As researchers further explore protein modifications, interactions, and functions, Western blotting remains an indispensable tool for validating scientific discoveries. The ability to precisely identify and quantify specific proteins is vital for progressing therapeutic target identification and understanding disease mechanisms. Within drug discovery, this method facilitates the evaluation of new drug candidates and their effects on cellular protein expression. Emphasizing the massive investments in protein analysis applications, BioSpace noted in March 2026 that the 16 largest pharmaceutical firms spent a combined $159 billion on research and development during 2025. This ongoing financial dedication to pharmaceutical R&D ensures a persistent need for dependable protein analysis techniques such as Western blotting.

Furthermore, the strong growth of the pharmaceutical and biotechnology sectors acts as a key driver for the market. This industry expansion creates a growing demand for sophisticated instruments that aid in drug creation, quality assurance, and the manufacturing of biosimilars and biologics. In these fields, Western blotting is extensively utilized to check antibody specificity, monitor expression levels, and verify protein purity, thereby guaranteeing the safety and effectiveness of novel therapies. Illustrating this dynamic landscape, Xtalks noted in December 2025 that major pharmaceutical entities spent upwards of $36 billion on biotech buyouts just in October and November 2025, a trend that demands thorough protein characterization. These considerable mergers and acquisitions highlight continuous industry expansion and consolidation, directly boosting the need for protein analysis tools. Correspondingly, Bio-Rad Laboratories, a major supplier of clinical diagnostics and life science products, reported full-year net sales of $2,583.2 million in 2025.

Market Challenge

The Global Western blotting market faces a major hurdle in the form of steep costs for its essential reagents and specialized equipment. These financial constraints severely limit broader adoption, disproportionately affecting emerging diagnostic labs, smaller research groups, and academic institutions operating on restricted budgets. The heavy initial capital needed for sophisticated machinery, combined with the recurring costs of premium detection chemistries, membranes, and antibodies, imposes significant financial strain on these establishments.

Even with substantial funding in the wider biopharmaceutical industry-highlighted by the Biotechnology Innovation Organization (BIO) reporting $26 billion in biopharma venture capital investments for 2024-the high individual costs for Western blotting resources hinder the market's ability to rapidly expand and penetrate various clinical and research settings. These persistent expenses stop numerous prospective users from buying new systems or upgrading their current Western blotting setups. Consequently, this leads to postponed adoption or a prolonged dependence on outdated, less effective technologies.

Market Trends

The Global Western Blotting Market is being transformed by the growing integration of high-throughput and automated systems, which greatly improve reproducibility and efficiency. By overcoming the common drawbacks of manual procedures, such as heavy hands-on time and experimental inconsistencies, these innovations enable scientists to handle larger sample volumes more reliably. The transition to automated processes speeds up research and development timelines, especially within the biotechnology and pharmaceutical sectors where extensive validation and screening are standard practice. Highlighting this trend, an article from the European Biotechnology Magazine on February 3, 2026, detailed that the major life science firm Sartorius invested EUR 442 million in 2025. This funding, partly aimed at expanding its bioprocess production network, illustrates the sector's dedication to scaling operations and embracing highly efficient, automated workflows.

Alongside automation, the rise of gel-free and miniaturized electrophoresis platforms is accelerating market expansion by delivering quicker, more user-friendly, and frequently higher-resolution protein assessments. By removing the necessity for conventional gels, these systems lower reagent and sample usage while ensuring faster results, a vital feature for swift decision-making in diagnostic and research contexts. The incorporation of these sleek, space-saving platforms encourages their use across a variety of lab environments, particularly those requiring decentralized testing or operating with limited room. Emphasizing the rising demand for these modern solutions, Bio-Techne Corporation's Fourth Quarter Fiscal 2025 Results, released on August 6, 2025, revealed that its Protein Sciences division-featuring the Simple Western platforms-reached $226.5 million in net sales for that quarter, marking a 6% year-over-year growth.

Key Market Players

  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche Ltd.
  • Danaher Corporation
  • EMD Millipore Corporation.
  • Bio-Rad Laboratories, Inc.
  • PerkinElmer Inc.
  • LI-COR, Inc.
  • Bio-Techne Corporation
  • QIAGEN N.V.
  • Advansta Inc.

Report Scope

In this report, the Global Western Blotting Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Western Blotting Market, By Product

  • Instruments
  • Consumables

Western Blotting Market, By Application

  • Biomedical biochemical research
  • Disease Diagnostics
  • Agriculture
  • Food & Beverages
  • Other Applications

Western Blotting Market, By End User

  • Diagnostic Laboratories
  • Research Institutions
  • Pharmaceutical & Biotechnology Companies

Western Blotting Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Western Blotting Market.

Available Customizations:

Global Western Blotting Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Western Blotting Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Instruments, Consumables)
    • 5.2.2. By Application (Biomedical biochemical research, Disease Diagnostics, Agriculture, Food & Beverages, Other Applications)
    • 5.2.3. By End User (Diagnostic Laboratories, Research Institutions, Pharmaceutical & Biotechnology Companies)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Western Blotting Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Application
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Western Blotting Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Western Blotting Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Western Blotting Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End User

7. Europe Western Blotting Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Application
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Western Blotting Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
    • 7.3.2. France Western Blotting Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Western Blotting Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Western Blotting Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Western Blotting Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End User

8. Asia Pacific Western Blotting Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Western Blotting Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. India Western Blotting Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Western Blotting Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Western Blotting Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Western Blotting Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. Middle East & Africa Western Blotting Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Application
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Western Blotting Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. UAE Western Blotting Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. South Africa Western Blotting Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User

10. South America Western Blotting Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Application
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Western Blotting Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Colombia Western Blotting Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. Argentina Western Blotting Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Western Blotting Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Thermo Fisher Scientific Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. F. Hoffmann-La Roche Ltd.
  • 15.3. Danaher Corporation
  • 15.4. EMD Millipore Corporation.
  • 15.5. Bio-Rad Laboratories, Inc.
  • 15.6. PerkinElmer Inc.
  • 15.7. LI-COR, Inc.
  • 15.8. Bio-Techne Corporation
  • 15.9. QIAGEN N.V.
  • 15.10. Advansta Inc.

16. Strategic Recommendations

17. About Us & Disclaimer